Company Filing History:
Years Active: 2021
Title: Steve Lacroix: Innovator in Parkinson's Disease Assessment
Introduction
Steve Lacroix is a notable inventor based in Lévis, Canada. He has made significant contributions to the field of medical research, particularly in the assessment of Parkinson's disease. His innovative approach utilizes erythrocyte-derived extracellular vesicles as biomarkers for clinical evaluation.
Latest Patents
Lacroix holds a patent titled "Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease." This patent outlines methods for clinically assessing Parkinson's disease in a subject using erythrocyte-derived extracellular vesicles (EEV) as a biomarker. This groundbreaking work has the potential to enhance the accuracy of Parkinson's disease diagnosis and monitoring.
Career Highlights
Steve Lacroix is affiliated with Université Laval, where he continues to advance his research and contribute to the scientific community. His work is recognized for its innovative approach and potential impact on clinical practices.
Collaborations
Lacroix collaborates with esteemed colleagues, including Francesca Cicchetti and Eric Boilard. These partnerships enhance the research efforts and broaden the scope of their investigations into Parkinson's disease.
Conclusion
Steve Lacroix's contributions to the field of medical research, particularly in the assessment of Parkinson's disease, highlight his innovative spirit and dedication to improving clinical practices. His work with erythrocyte-derived extracellular vesicles represents a significant advancement in the understanding and diagnosis of this complex disease.